← All Sponsors
SPONSOR

Cytokinetics

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Heart FailureHeart Failure With Reduced Ejection Fraction
NCT06736574 Phase 3
Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Heart Failure
United States, Canada, France View Trial →